Clin Endosc.  2017 Nov;50(6):552-561. 10.5946/ce.2017.032.

Endoscopic Sleeve Gastroplasty - A New Tool to Manage Obesity

Affiliations
  • 1Division of Gastroenterology, Department of Internal Medicine, Albert Einstein Medical Center, Philadelphia, PA, USA.
  • 2Division of Gastroenterology, Hepatology and Nutrition, University of Texas Health Science Center at Houston, Houston, TX, USA. sdsinghal@gmail.com

Abstract

Obesity is a growing pandemic across the world. Dietary restrictions and behavior modifications alone have a limited benefit. Bariatric surgery, despite being the current gold standard, has limited acceptance by patients due to cost and associated morbidity. In our review, we have discussed nine original studies describing endoscopic sleeve gastroplasty (ESG). A total of 172 subjects successfully underwent ESG. Of 65 subjects with follow up data, 95.4% (62/65) had intact gastric sleeve confirmed via esophagogastroduodenoscopy or oral contrast study at the end of study specific follow up interval (the longest being 6 months). Individual studies reported a technical success rate for intact gastric sleeve from as low as 50% to as high as 100%. A statistically significant p < 0.05) weight loss was reported in seven of the eight studies with available data. None of the patients experienced any intra-procedure complications, and approximately 2.3% (4/172) of patients experienced major post-procedure complications; however, no mortality was reported. Majority of the studies reported relatively high incidence of minor post-procedure complications, which improved with symptomatic treatment alone. Good patient tolerance with comparable clinical efficacy in achieving and sustaining desired weight loss makes ESG an attractive option to consider among other bariatric therapies.

Keyword

Endoscopic sleeve gastroplasty; Obesity; Endoscopic bariatric therapy; Body mass index; Extra weight loss

MeSH Terms

Bariatric Surgery
Behavior Therapy
Body Mass Index
Endoscopy, Digestive System
Follow-Up Studies
Gastroplasty*
Humans
Incidence
Mortality
Obesity*
Pandemics
Treatment Outcome
Weight Loss

Reference

1. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016; 315:2284–2291.
Article
2. Trust for America’s Health. The state of obesity 2016 [Internet]. Washington, DC: Trust for America’s Health;c2016. [updated 2016 Sep; cited 2016 Nov 5]. Available from: http://stateofobesity.org/files/stateofobesity2016.pdf.
3. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med. 2006; 355:763–778.
Article
4. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014; 149:275–287.
5. Buchwald H, Oien DM. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013; 23:427–436.
Article
6. Jain D, Singhal S. Endoscopic bypass using endobarrier devices: efficacy in treating obesity and metabolic syndrome. J Clin Gastroenterol. 2015; 49:799–803.
7. Goyal D, Watson RR. Endoscopic bariatric therapies. Curr Gastroenterol Rep. 2016; 18:26.
Article
8. Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013; 78:530–535.
Article
9. Sharaiha RZ, Kedia P, Kumta N, et al. Initial experience with endoscopic sleeve gastroplasty: technical success and reproducibility in the bariatric population. Endoscopy. 2015; 47:164–166.
Article
10. Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017; 15:504–510.
Article
11. Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017; 15:37–43.e1.
12. Lopez-Nava G, Galvão MP, da Bautista-Castaño I, Jimenez A, De Grado T, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2015; 47:449–452.
Article
13. Lopez-Nava G, Galvão MP, Bautista-Castaño I, Jimenez-Baños A, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty: how I do it? Obes Surg. 2015; 25:1534–1538.
Article
14. Lopez-Nava G, Galvao M, Bautista-Castaño I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016; 4:E222–E227.
Article
15. López-Nava Breviere G, Bautista-Castaño I, Fernández-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty (the Apollo method): a new approach to obesity management. Rev Esp Enferm Dig. 2016; 108:201–206.
Article
16. Galvão-Neto MD, Grecco E, Souza TF, Quadros LG, Silva LB, Campos JM. Endoscopic sleeve gastroplasty - minimally invasive therapy for primary obesity treatment. Arq Bras Cir Dig. 2016; 29(Suppl 1):95–97.
Full Text Links
  • CE
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr